223 related articles for article (PubMed ID: 2167954)
1. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1990 Sep; 8(9):1563-74. PubMed ID: 2167954
[TBL] [Abstract][Full Text] [Related]
2. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
Albain KS; Crowley JJ; LeBlanc M; Livingston RB
J Clin Oncol; 1991 Sep; 9(9):1618-26. PubMed ID: 1651993
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Albain KS; Crowley JJ; Livingston RB
Chest; 1991 Jun; 99(6):1425-32. PubMed ID: 2036826
[TBL] [Abstract][Full Text] [Related]
4. Small-cell carcinoma of the lung: derivation of a prognostic staging system.
Sagman U; Maki E; Evans WK; Warr D; Shepherd FA; Sculier JP; Haddad R; Payne D; Pringle JF; Yeoh JL
J Clin Oncol; 1991 Sep; 9(9):1639-49. PubMed ID: 1651996
[TBL] [Abstract][Full Text] [Related]
5. Prognostic influence of TNM staging and LDH levels in small cell carcinoma of the lung (SCCL).
Byhardt RW; Hartz A; Libnoch JA; Hansen R; Cox JD
Int J Radiat Oncol Biol Phys; 1986 May; 12(5):771-7. PubMed ID: 3011712
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung cancer: analysis of factors influencing the response to treatment and survival.
de Wet M; Falkson G; Rapoport BL
Oncology; 1994; 51(6):523-34. PubMed ID: 7970498
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
J Clin Oncol; 1991 Jun; 9(6):954-61. PubMed ID: 1851821
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.
Spiegelman D; Maurer LH; Ware JH; Perry MC; Chahinian AP; Comis R; Eaton W; Zimmer B; Green M
J Clin Oncol; 1989 Mar; 7(3):344-54. PubMed ID: 2537384
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Foster NR; Mandrekar SJ; Schild SE; Nelson GD; Rowland KM; Deming RL; Kozelsky TF; Marks RS; Jett JR; Adjei AA
Cancer; 2009 Jun; 115(12):2721-31. PubMed ID: 19402175
[TBL] [Abstract][Full Text] [Related]
10. Influence of age on the treatment of limited-stage small-cell lung cancer.
Siu LL; Shepherd FA; Murray N; Feld R; Pater J; Zee B
J Clin Oncol; 1996 Mar; 14(3):821-8. PubMed ID: 8622030
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and prognostic staging system for small cell lung cancer.
Kawahara M; Fukuoka M; Saijo N; Nishiwaki Y; Ikegami H; Tamura T; Shimoyama M; Suemasu K; Furuse K
Jpn J Clin Oncol; 1997 Jun; 27(3):158-65. PubMed ID: 9255270
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis.
Hermes A; Waschki B; Gatzemeier U; Reck M
Lung Cancer; 2011 Mar; 71(3):363-6. PubMed ID: 20619477
[TBL] [Abstract][Full Text] [Related]
13. Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
Albain KS; Green S; LeBlanc M; Rivkin S; O'Sullivan J; Osborne CK
Breast Cancer Res Treat; 1992; 22(3):273-84. PubMed ID: 1391993
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of pretreatment serum LDH in patients with limited disease small-cell lung carcinoma.
Stokkel MP; Van Eck-Smit BL; Zwinderman AH; Willems LN; Pauwels EK
Int J Biol Markers; 1997; 12(4):162-7. PubMed ID: 9582606
[TBL] [Abstract][Full Text] [Related]
15. [Prognosis of small cell lung cancer with ipsilateral pleural effusion].
Oomori H; Matsui K; Nakagawa K; Masuda N; Itoh K; Kudoh S; Takifuji S; Kusunoki Y; Takada M; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jun; 30(6):1085-90. PubMed ID: 1324375
[TBL] [Abstract][Full Text] [Related]
16. Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer--what limits limited disease?
Micke P; Faldum A; Metz T; Beeh KM; Bittinger F; Hengstler JG; Buhl R
Lung Cancer; 2002 Sep; 37(3):271-6. PubMed ID: 12234695
[TBL] [Abstract][Full Text] [Related]
17. Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Albain KS; Crowley JJ; Hutchins L; Gandara D; O'Bryan RM; Von Hoff DD; Griffin B; Livingston RB
Cancer; 1993 Aug; 72(4):1184-91. PubMed ID: 8393365
[TBL] [Abstract][Full Text] [Related]
18. Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.
Lara PN; Moon J; Redman MW; Semrad TJ; Kelly K; Allen J; Gitlitz B; Mack PC; Gandara DR
Clin Lung Cancer; 2016 Mar; 17(2):113-8.e1-2. PubMed ID: 26498504
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis in limited disease (LD) small cell lung cancer (SCLC) patients according to status performance, local extension of lesions, type of treatment and the completeness of staging].
Remiszewski P; Roszkowski-Sliz K; Wiatr E; Roszkowska-Sliz B; Zych J; Kurzyna M; Jodkiewicz Z; Rowińska-Zakrzewska E
Pneumonol Alergol Pol; 2003; 71(3-4):139-47. PubMed ID: 14587419
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials.
Tamura M; Ueoka H; Kiura K; Tabata M; Shibayama T; Miyatake K; Gemba K; Hiraki S; Harada M
Acta Med Okayama; 1998 Apr; 52(2):105-11. PubMed ID: 9588226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
